These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 6757010

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Insulin treatment reverses the postreceptor defect in adipocyte 3-O-methylglucose transport in type II diabetes mellitus.
    Scarlett JA, Kolterman OG, Ciaraldi TP, Kao M, Olefsky JM.
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1195-201. PubMed ID: 6341390
    [Abstract] [Full Text] [Related]

  • 3. Mechanisms of insulin resistance in obesity and noninsulin-dependent (type II) diabetes.
    Olefsky JM, Kolterman OG.
    Am J Med; 1981 Jan; 70(1):151-68. PubMed ID: 7006388
    [Abstract] [Full Text] [Related]

  • 4. Insulin receptor binding and metabolic effects of insulin in human subcutaneous adipose tissue in untreated non-insulin dependent diabetes mellitus.
    Arner P, Engfeldt P, Skarfors E, Lithell H, Bolinder J.
    Ups J Med Sci; 1987 Jan; 92(1):47-58. PubMed ID: 3296383
    [Abstract] [Full Text] [Related]

  • 5. Effects of obesity, hyperinsulinemia, and glucose intolerance on insulin action in adipose tissue of sixty-year-old men.
    Bolinder J, Lithell H, Skarfors E, Arner P.
    Diabetes; 1986 Mar; 35(3):282-90. PubMed ID: 3512339
    [Abstract] [Full Text] [Related]

  • 6. Insulin treatment reverses the insulin resistance of type II diabetes mellitus.
    Scarlett JA, Gray RS, Griffin J, Olefsky JM, Kolterman OG.
    Diabetes Care; 1982 Mar; 5(4):353-63. PubMed ID: 6759075
    [No Abstract] [Full Text] [Related]

  • 7. Characterization of insulin resistance and NIDDM in transgenic mice with reduced brown fat.
    Hamann A, Benecke H, Le Marchand-Brustel Y, Susulic VS, Lowell BB, Flier JS.
    Diabetes; 1995 Nov; 44(11):1266-73. PubMed ID: 7589822
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Postreceptor defects causing insulin resistance in normoinsulinemic non-insulin-dependent diabetes mellitus.
    Bolinder J, Ostman J, Arner P.
    Diabetes; 1982 Oct; 31(10):911-6. PubMed ID: 6759224
    [Abstract] [Full Text] [Related]

  • 10. Insulin-receptor autophosphorylation and endogenous substrate phosphorylation in human adipocytes from control, obese, and NIDDM subjects.
    Thies RS, Molina JM, Ciaraldi TP, Freidenberg GR, Olefsky JM.
    Diabetes; 1990 Feb; 39(2):250-9. PubMed ID: 2227134
    [Abstract] [Full Text] [Related]

  • 11. Insulin induces progressive insulin resistance in cultured rat adipocytes. Sequential effects at receptor and multiple postreceptor sites.
    Garvey WT, Olefsky JM, Marshall S.
    Diabetes; 1986 Mar; 35(3):258-67. PubMed ID: 3512337
    [Abstract] [Full Text] [Related]

  • 12. Pathogenesis of type 2 diabetes mellitus: an interpretation of current data.
    Davidson MB.
    Am J Med Sci; 1986 Jul; 292(1):35-9. PubMed ID: 3521280
    [Abstract] [Full Text] [Related]

  • 13. [The possible role of adipose tissue in insulin resistance and in the physiopathology of obese diabetics].
    Guy-Grand B, Bour H.
    Journ Annu Diabetol Hotel Dieu; 1972 Jul; 13(0):81-92. PubMed ID: 4606004
    [No Abstract] [Full Text] [Related]

  • 14. Inter-relationship between insulin secretion and plasma free fatty acid and triglyceride transport kinetics in maturity onset diabetes and the effect of phenethylbiguanide (phenformin).
    Kissebah AH, Adams PW, Wynn V.
    Diabetologia; 1974 Apr; 10(2):119-30. PubMed ID: 4844187
    [No Abstract] [Full Text] [Related]

  • 15. Defective non-insulin-mediated and insulin-mediated glucose transport and metabolism in adipocytes from obese and lean patients with untreated type 2 diabetes mellitus.
    Hjøllund E, Beck-Nielsen H, Pedersen O, Richelsen B, Sørensen NS.
    Diabet Med; 1985 Nov; 2(6):468-73. PubMed ID: 2951120
    [Abstract] [Full Text] [Related]

  • 16. [Tissue insulin sensitivity and its role in the pathogenesis of diabetes mellitus].
    Iaroshevskiĭ IuA.
    Probl Endokrinol (Mosk); 1980 Nov; 26(5):81-9. PubMed ID: 7001441
    [No Abstract] [Full Text] [Related]

  • 17. Mechanism of insulin resistance in human liver cirrhosis. Evidence of a combined receptor and postreceptor defect.
    Cavallo-Perin P, Cassader M, Bozzo C, Bruno A, Nuccio P, Dall'Omo AM, Marucci M, Pagano G.
    J Clin Invest; 1985 May; 75(5):1659-65. PubMed ID: 3889056
    [Abstract] [Full Text] [Related]

  • 18. Insulin resistance: receptor and post-binding defects in human obesity and non-insulin-dependent diabetes mellitus.
    Truglia JA, Livingston JN, Lockwood DH.
    Am J Med; 1985 Aug 23; 79(2B):13-22. PubMed ID: 3898828
    [Abstract] [Full Text] [Related]

  • 19. Cellular alterations in liver, skeletal muscle, and adipose tissue responsible for insulin resistance in obesity and type II diabetes.
    Caro JF, Dohm LG, Pories WJ, Sinha MK.
    Diabetes Metab Rev; 1989 Dec 23; 5(8):665-89. PubMed ID: 2693017
    [No Abstract] [Full Text] [Related]

  • 20. Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects.
    Kolterman OG, Insel J, Saekow M, Olefsky JM.
    J Clin Invest; 1980 Jun 23; 65(6):1272-84. PubMed ID: 6997333
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.